glp 1 binge eating GLP-1 Medications and Disordered Eating: A Personalized, Evidence-Based Approach New research from our team

Inhibition of cholesteryl-ester formation, for example, through targeting ACAT2, or dampening SREBF2 activity, may synergize with immune checkpoint blockade or adoptive NK cell therapies to overcome tumor immune evasion

Front Med (Lausanne) 2022;9:793203

doi: 10.1073/pnas.1523926113 182 MatsumotoGShimogoriTHattoriNNukinaN

This "triple threat" approach is designed to tackle metabolic dysfunction from three distinct angles: appetite suppression, glucose regulation, and calorie burning

If you are uncertain about your specific dosing regimen or have questions about timing, your GP or prescribing clinician can provide personalised guidance based on your treatment plan and the specific product information for your medication